Supply Chain

The following drug companies made headlines in the past two weeks.

Columbus, Ohio-based West-Ward Pharmaceuticals — the U.S. subsidiary of London-based Hikma Pharmaceuticals — increased the price of a common diarrhea drug by 430 percent, reports Financial Times.

House Democrats are investigating the high price of multiple sclerosis drugs in the U.S., reports Bloomberg.

Here are the five latest drugs or medical devices approved by the Food and Drug Administration since August 4.

The Food and Drug Administration on Thursday granted expanded approval for AstraZeneca's cancer drug Lynaparza.

The Food and Drug Administration on Thursday approved Pfizer's leukemia drug Besponsa, reports Reuters.

Stryker on Wednesday earned Food and Drug Administration clearance for its Serrato Pedicle Screw.

You have adopted an innovative mindset and are thinking outside of the box about supply chain management– what’s next? Execute.

Here are seven articles published by Becker's Hospital Review in the last week, which highlight a nationwide depletion of Sanofi Pasteur's yellow fever vaccine, Intermountain's 2014 Supplier Award winners and more.

Mylan on Thursday finalized a $465 million settlement with the federal government over accusations the Canonsburg, Pa.-based drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid, reports CNBC.